Bank Of Montreal Cytom X Therapeutics, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.41 - $2.74 $51,324 - $99,736	36,400 Added 51.05%	107,700 $234,000
Q4 2023 Feb 08, 2024	BUY	$1.07 - $1.55 $76,291 - $110,515	71,300 New	71,300 $110,000
Q4 2022 Feb 01, 2023	BUY	$1.19 - $1.91 $82,824 - $132,936	69,600 New	69,600 $111,000
Q3 2021 Nov 12, 2021	SELL	$4.32 - $6.43 $843,078 - $1.25 Million	-195,157 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$6.33 - $9.91 $1.24 Million - $1.93 Million	195,157 New	195,157 $1.28 Million

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.